Gilead Sciences to provide at least 4,50,000 vials of Remdesivir to India
The Hindu
Gilead Sciences, the U.S. manufacturers of anti-viral drug remdesivir, used in the treatment of COVID-19, has announced that it will donate at least 4,50,000 vials of the injection, under the brand na
Gilead Sciences, the U.S. manufacturers of , used in the treatment of , has announced that it will donate at least 4,50,000 vials of the injection, under the brand name Veklury, to the Government of India, as the country is facing a shortage of the drug. Russia had planned to supply up to 4,00,000 doses of the anti-viral but those plans had run into trouble over intellectual property rights. The Indian government was trying to procure them directly from the U.S. as a consequence, . Gilead said on Monday that it will provide technical assistance to its seven Indian licensees so they can expand production capacity and donate active pharmaceutical ingredients (API). Last week, the Centre had announced that India’s monthly production capacity was being increased from 3.8 million (38 lakhs) vials to 7.4 million (74 lakhs).More Related News
One dies, eight hospitalised after inhaling HCL fumes at pharma company in Andhra Pradesh’s Anakapalli district. About 400 litres of HCL leaked from the reactor-cum-receiver tank at Unit-III of the company, which affected nine workers, says Collector. While the condition of six of them is stable, two are on ventilator support. Chief Minister Chandrababu Naidu directs authorities to provide advanced treatment to the victims. Home Minister Anitha expresses anger over repeated such incidents.